WASHINGTON--(BUSINESS WIRE)--Biotechnology Innovation Organization (BIO) President & CEO James C. Greenwood today issued the following statement on the Hatch-Waxman Integrity Act of 2018: “For almost ...
Washington, D.C. (March 9, 2016) –Biotechnology Innovation Organization (BIO) Executive Vice President for Health Policy Dan Durham released the following statement regarding yesterday's proposed Part ...
WASHINGTON--(BUSINESS WIRE)--BIO President and CEO Jim Greenwood issued the following statement regarding today’s proposed changes to Medicare Part D and Medicare Advantage plans: “Today’s proposed ...
Washington, D.C. (October 4, 2015) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement today: "We are very disappointed in reports from Atlanta ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback